The 20 Best Large-Cell Lung Carcinoma Doctors Near Me in Ann Arbor, MI

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

Dr. De Cardenas is the Director of the Interventional Pulmonology Program at the University of Michigan and a Clinical Associate Professor of Medicine and Surgery. He is part of the multidisciplinary team at the University of Michigan that treats patients with complex airway and pleural diseases. He has specific expertise in minimally invasive advanced diagnostic and therapeutic bronchoscopic and pleural procedures, critical care ultrasonography and medical education. His academic interests include endobronchial device development for treatment of early lung cancer, pleural infectious diseases, and developing novel methods to teach procedural skills.Honors and Awards:2017 Nominee Emerging Educator Award - Association of Pulmonary and Critical Care Medicine Program Directors (APCCMPD)2014 Fellow of the Year, Department of Medicine. Zucker School of Medicine at Hofstra Northwell, NY2012 Best Teaching Senior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2011 Best Teaching Junior Resident, Leo M. Davidoff Society Awards, Albert Einstein College of Medicine2010 Best Teaching Intern, Leo M. Davidoff Society Awards, Albert Einstein College of MedicineCredentials:Medical SchoolMD, Facultad de Medicina. Universidad Nacional de Trujillo, Peru 2006ResidencyAlbert Einstein College of Medicine, Jacobi Medical Center, Internal Medicine, NY 2012FellowshipsHarvard Medical School, Combined Interventional Pulmonology Fellowship. Beth Israel Deaconess Medical and Massachusetts General Hospital, Boston, MA, 2016Zucker School of Medicine. Pulmonary and Critical Care Medicine, North Shore University Hospital and Long Island Jewish Medical Center, NY 2015Board Certifications2012: Board Certification in Internal Medicine2014: Board Certification in Pulmonary Medicine2016: Board Certification in Critical Care Medicine2017: Board Certification in Interventional Pulmonology. AABIP. Dr. De Cardenas is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Advanced Bronchoscopy, and Endoscopy. Dr. De Cardenas is board certified in Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonology.

Dr. Hyzy is the Medical Director of the Critical Care Medicine Unit and Co-Chair of the Critical Care Committee at the University of Michigan Hospital. Dr. Hyzy is a graduate of Kenyon College and NYU School of Medicine and trained in Internal Medicine and Pulmonary and Critical Care Medicine at the University of Michigan. Dr. Hyzy’s research interest in thin the intensive care unit including patients with the Acute Respiratory Distress Syndrome, sepsis and respiratory failure. In the Pulmonary Clinic he participated as a Co-Investigator in clinical trials in patients with Idiopathic Pulmonary Fibrosis and COPD. Dr. Hyzy is an active clinician and researcher with multiple publications including serving as editor of a critical care textbook published by Springer and 14 topics to the online medical reference UpToDate. Dr. Hyzy is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

Max Wayne is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Wayne is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Pulmonary Alveolar Proteinosis, Lymphofollicular Hyperplasia, Endoscopy, and Pancreaticoduodenectomy.

Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Regenbogen is rated as a Distinguished provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Nithya Ramnath is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Ramnath is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Advanced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.

Mario Lacerna is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lacerna is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Lacerna is board certified in Radiation Oncology.

Medical school: Creighton University School of Medicine; Internship: University of Michigan Hospitals- Pediatrics/Internal Medicine; Residency: University of Cleveland Hospitals- Radiation Oncology. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Breast Cancer. Dr. Kane is board certified in Radiation Oncology.

Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. Hearn is an Associate Professor in the Department of Radiation Oncology at the University of Michigan. He completed his medical training at Harvard Medical School and his residency in radiation oncology at Cleveland Clinic. Dr. Hearn investigates mechanisms by which prostate cancer may become resistant to current treatments.Dr. Hearn also treats bladder cancer and has been impressed by the promising responses (sometimes dramatic and long-lasting) that some patients with bladder cancer have when treated with immunotherapy to harness the body’s immune system. He is interested in the intersection of immunotherapy and radiation therapy.Additionally, Dr. Hearn is interested in novel techniques to improve the safety and efficacy of radiation therapy for lung cancer by modulating cytokines relevant to lung injury. Dr. Hearn is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Hearn is board certified in Radiation Oncology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Gay is an Associate Professor of Internal Medicine, Medical Director of Critical Care Support Services, and the Assistant Dean for Medical School Admissions at the University of Michigan in Ann Arbor, Michigan. His clinical and research interests include medical education, outcomes, and treatments for end-stage lung disease, lung transplantation, interventional bronchoscopy, and the evaluation of unexplained dyspnea.Dr. Gay is board certified in pulmonary medicine, and critical care medicine. He received his undergraduate degree from Yale University and received his medical degree at the University of Illinois at Chicago College of Medicine. He served his internship and residency in internal medicine at Michael Reese Medical Center in Chicago. After completing a fellowship in pulmonary and critical care medicine at the University of Michigan Medical Center, Dr. Gay earned a master's degree in clinical study design and biostatistics at the University of Michigan School of Public Health, Ann Arbor. Dr. Gay is a member of the American Thoracic Society, the American Association of Medical Colleges, and has served as a consultant to the FDA Advisory Committee on Pulmonary and Allergy Medications. Dr. Gay is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Pulmonary Alveolar Proteinosis, Emphysema, Lung Metastases, and Acute Interstitial Pneumonia.

Emily Ducomb is an Internal Medicine specialist and a Pulmonary Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Ducomb is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Lung Nodules, Lymphofollicular Hyperplasia, Acquired Tracheomalacia, and Tracheobronchomalacia.

Michael Coffey is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 44 years. Dr. Coffey is rated as an Experienced provider by MediFind in the treatment of Large-Cell Lung Carcinoma. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Bronchiolitis Obliterans, Industrial Bronchitis, Acute Interstitial Pneumonia, and Interstitial Lung Disease.